定位手術装置の世界市場規模：製品タイプ別、用途別、地域範囲別および予測

定位手術装置の市場規模と予測

定位手術装置市場規模は、2024年に191億5,000万米ドルと評価され、2026年から2032年にかけてCAGR 4.74%で成長し、2032年には277億3,000万米ドルに達すると予測されています。

• 定位手術装置は、特に脳疾患、腫瘍、特定の神経疾患の治療において、外科手術中の正確なターゲティングを可能にする最新の医療機器です。これらの技術は、MRI、CTスキャン、X線などの画像技術を使用して3次元座標系を提供し、外科医が脳の特定部位やその他の解剖学的構造を正確に突き止めて手術することを可能にします。定位手術の応用には、定位放射線手術、生検治療、脳深部刺激電極植え込みなどがあり、これらはすべて、患者の回復時間を短縮し、手術結果を向上させる低侵襲な選択肢を提供します。
• 画像技術、ロボットシステム、人工知能の進歩により、定位手術装置の可能性は楽観視できます。これらの技術が進歩すれば、外科治療の精度と有効性が向上し、より困難な手術も安全に行えるようになると予測されます。
• 神経疾患の有病率の増加や高齢化により、これらの機器の需要が高まると予想されます。遠隔医療や遠隔手術機能との統合は、定位治療の範囲を広げる可能性があり、恵まれない地域でも専門的な治療が受けやすくなります。

定位手術装置の世界市場力学

世界の定位手術装置市場を形成している主な市場力学は以下の通り：

主な市場促進要因

• 神経疾患の有病率の増加：神経疾患の有病率の増加：神経疾患の有病率の増加は、正確な診断と治療の選択の必要性が高まっているため、定位手術装置市場を牽引しています。世界保健機関（WHO）の報告によると、神経疾患は世界中で障害調整生存年数（DALY）の最大の原因であり、死亡原因の第2位です。世界疾病負担調査（Global Burden of Disease Study 2019）によると、これらの病気は世界で2億8,000万DALYを占めています。このような負担の増大には、より正確で回復時間の短い新しい外科手術が必要であり、洗練された定位手術技術に対する需要を牽引しています。
• 低侵襲手術の採用拡大：侵襲性の低い外科的処置の使用の増加は、回復時間の短縮や合併症発生率の低下といったいくつかの利点を提供する定位手術機器に対する需要を高めています。米国形成外科学会によると、低侵襲の美容整形手術は2000年から2020年の間に174％増加しました。Journal of Neurosurgery誌の調査によると、脳腫瘍手術における低侵襲手術の使用率は、2010年の2％から2019年には12％に増加しました。この開発は、より正確で外傷の少ない手術法へのシフトを示しており、このような治療を支援する高度な定位技術への需要が高まっています。
• イメージング技術の進歩：画像技術の進歩は、定位手術の精度と有効性を大幅に向上させ、その結果、定位手術器具の市場成長をもたらしています。経済協力開発機構（OECD）は、OECD諸国における人口100万人当たりのMRI装置は2013年の15.5台から2019年には17.4台に増加し、CTスキャナーは同期間に24.1台から27.8台に増加したと報告しています。こうした画像技術の進歩により、外科医はより正確な解剖学的情報を得ることができるようになり、その結果、より効果的な介入が可能になり、患者の転帰も改善されます。画像技術の進歩に伴い、これらのブレークスルーを活用した先進的な定位装置への需要が高まると思われます。

主な課題

• 患者の安全性への懸念：その利点にもかかわらず、定位手技の精度は、患者の動きや解剖学的な違いなどの要因によって妨げられる可能性があります。このような安全性の問題は、外科医のためらいの原因となります。これらの問題を解決することは、精度と患者の安全性を高める、より複雑な画像技術やリアルタイム・モニタリング・システムの開発を促し、市場の革新を促進します。
• 熟練専門家の不足：定位手術に使用される最新技術を理解し、操作できる熟練者の需要が高まっています。訓練を受けたスタッフの不足は、業界の拡大を妨げる可能性があります。この困難は、教育イニシアティブやトレーニングプログラムへの投資を促進し、最終的にはより有能なスタッフを輩出し、より多くの施設がこれらの新しい外科技術を効率的に使用できるようにします。
• 技術の陳腐化：急速な技術向上は、既存の定位装置を陳腐化させる可能性があり、これらのシステムに多額の投資を行う医療施設にとって、陳腐化の心配が生じる。これは困難ではあるが、メーカーにとっては、最近の動向を組み合わせた次世代技術の研究開発を継続し、定位手術の能力と有効性を継続的に向上させる動機付けとなります。

主要動向：

• ロボット支援手術の使用の増加：定位手術におけるロボット機器の使用は人気を集めており、治療中の精度と制御を向上させています。ロボット工学は手術結果を改善し、療養期間を短縮します。この動向は、病院が市場競争力を維持し、患者ケアを向上させ、より良い結果を得るために革新的な技術を導入しようとしているため、市場の拡大を後押ししており、最終的にはより多くの患者を惹きつけています。
• 個別化医療のアプローチ：個別化医療の動きは定位手術装置市場に影響を与えています。患者固有の特徴に合わせて治療法を調整することで、手術成績が向上する可能性があります。この戦略を採用する医療従事者が増えるにつれて、オーダーメイドの治療プログラムに対応できる先進的な定位手術装置への需要が高まり、技術革新が促進され、市場の将来性が拡大します。
• ヘルスケア・インフラへの投資の増加：多くの国が、手術能力を向上させ、新しい医療技術へのアクセスを提供するために、ヘルスケア・インフラへの投資を進めています。この動向は、病院や診療所が施設の近代化とサービス提供の拡大を目指す中で、定位手術技術の使用を後押ししています。投資の増加は高度な手術機器への需要を高め、結果として市場全体の成長をもたらします。

目次

第1章 定位手術装置の世界市場イントロダクション

• 市場概要
• 調査範囲
• 前提条件

第2章 エグゼクティブサマリー

第3章 VERIFIED MARKET RESEARCHの調査手法

• データマイニング
• バリデーション
• 一次資料
• データソース一覧

第4章 定位手術装置の世界市場展望

• 概要
• 市場力学
  • 促進要因
  • 抑制要因
  • 機会
• ポーターのファイブフォースモデル
• バリューチェーン分析

第5章 定位手術装置の世界市場：製品タイプ別

• 概要
• ガンマナイフ
• ライン加速器（リニアック）
• 陽子線
• サイバーナイフ

第6章 定位手術装置の世界市場：用途別

• 概要
• 動静脈奇形治療
• 脳腫瘍治療
• てんかん治療
• パーキンソン病
• 三叉神経痛

第7章 定位手術装置の世界市場、地域別

• 概要
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • その他の欧州
• アジア太平洋
  • 中国
  • 日本
  • インド
  • その他のアジア太平洋
• 世界のその他の地域
  • ラテンアメリカ
  • 中東・アフリカ

第8章 定位手術装置の世界市場競争情勢

• 概要
• 各社の市場ランキング
• 主な発展戦略

第9章 企業プロファイル

• Ion Beam Applications S.A.
• Mevion Medical Systems
• Varian Medical Systems
• Monteris Medical
• Elekta AB
• Micromar
• Accuracy Incorporated
• Inomed
• Alliance Oncology
• Medical AG

第10章 付録

• 関連調査

Stereotactic Surgery Devices Market Size and Forecast

Stereotactic Surgery Devices Market size was valued at USD 19.15 Billion in 2024 and is projected to reach USD 27.73 Billion by 2032, growing at a CAGR of 4.74% from 2026 to 2032.

• Stereotactic surgery devices are modern medical instruments that allow for accurate targeting during surgical procedures, particularly in the treatment of brain diseases, tumors, and certain neurological conditions. These technologies use imaging techniques like MRI, CT scans, and X-rays to provide a three-dimensional coordinate system, allowing surgeons to precisely pinpoint and operate on specific parts of the brain or other anatomical structures. Stereotactic surgery applications include stereotactic radiosurgery, biopsy treatments, and deep brain stimulation electrode implantation, all of which offer minimally invasive choices that reduce patient recovery time and enhance surgical outcomes.
• The potential of stereotactic surgery equipment seems optimistic, thanks to advances in imaging technology, robotic systems, and artificial intelligence. As these technologies advance, they are projected to improve the precision and efficacy of surgical treatments, enabling more difficult procedures to be performed safely.
• The increasing prevalence of neurological disorders, as well as the aging population, are expected to drive up demand for these devices. Integration with telemedicine and remote surgery capabilities may potentially broaden the scope of stereotactic treatments, making specialized care more accessible in underprivileged areas.

Global Stereotactic Surgery Devices Market Dynamics

The key market dynamics that are shaping the global stereotactic surgery devices market include:

Key Market Drivers:

• Increasing Prevalence of Neurological Disorders: The increased prevalence of neurological disorders is driving the stereotactic surgery devices market, as there is a greater need for precise diagnosis and treatment choices. The World Health Organization (WHO) reports that neurological illnesses are the largest cause of disability-adjusted life years (DALYs) and the second highest cause of mortality worldwide. According to the Global Burden of Disease Study 2019, these illnesses account for 280 million DALYs worldwide. This growing burden needs new surgical procedures that provide more accuracy and shorter recovery times, driving demand for sophisticated stereotactic surgery technologies.
• Growing Adoption of Minimally Invasive Surgical Procedures: The increased use of less invasive surgical procedures is driving up demand for stereotactic surgery instruments, which provide several benefits such as shorter recovery times and lower complication rates. According to the American Society of Plastic Surgeons, minimally invasive cosmetic operations increased by 174% between 2000 and 2020. Research in the Journal of Neurosurgery found that the usage of minimally invasive procedures for brain tumor surgery grew from 2% in 2010 to 12% in 2019. This development indicates a shift toward more accurate and less traumatic surgical methods, which is increasing the demand for advanced stereotactic technologies that aid such treatments.
• Advancements in Imaging Technologies: Imaging technology advancements are considerably improving the precision and efficacy of stereotactic procedures, resulting in market growth for stereotactic surgical instruments. The Organization for Economic Cooperation and Development (OECD) reported an increase in MRI units per million population in OECD countries from 15.5 in 2013 to 17.4 in 2019, while CT scanners increased from 24.1 to 27.8 during the same period. These advancements in imaging technologies allow surgeons to gain more precise anatomical information, resulting in more effective interventions and better patient outcomes. As imaging technology advances, there will be an increased demand for advanced stereotactic devices that take advantage of these breakthroughs.

Key Challenges:

• Patient Safety Concerns: Despite their benefits, the precision of stereotactic procedures might be hampered by factors such as patient movement or anatomical differences. These safety issues can cause hesitation among surgeons. Resolving these problems encourages the development of more complex imaging technologies and real-time monitoring systems that increase accuracy and patient safety, promoting market innovation.
• Shortage of Skilled Professionals: There is an increasing demand for skilled individuals who can operate and understand the latest technologies used in stereotactic surgery. The shortage of trained staff has the potential to hinder industry expansion. This difficulty promotes investment in educational initiatives and training programs, which will eventually assist in producing a more competent staff and ensure that more facilities can efficiently use these new surgical techniques.
• Technological Obsolescence: Rapid technological improvements might render existing stereotactic devices obsolete, raising worries about obsolescence for medical facilities that make significant investments in these systems. While this is a difficulty, it motivates manufacturers to continue researching and developing next-generation technologies that combine the most recent advances, hence continuously improving the capabilities and effectiveness of stereotactic procedures.

Key Trends:

• Increased Use of Robotic-Assisted Surgery: The use of robotic devices in stereotactic surgery is gaining popularity, improving precision and control during treatments. Robotics improves surgery results and shortens recuperation periods. This trend is propelling market expansion as hospitals attempt to implement innovative technologies in order to remain competitive, improve patient care, and achieve better results, ultimately attracting more patients.
• Personalized Medicine Approach: The personalized medicine movement is having an impact on the market for stereotactic surgery devices. Tailoring therapy to unique patient features can result in improved surgical outcomes. As more healthcare practitioners embrace this strategy, there is a greater demand for advanced stereotactic devices capable of accommodating tailored treatment programs, which drives innovation and expands market prospects.
• Increased Investment in Healthcare Infrastructure: Many countries are investing in healthcare infrastructure to improve surgical capabilities and provide access to new medical technologies. This trend encourages the use of stereotactic surgery technologies as hospitals and clinics look to modernize their facilities and expand their service offerings. Increased investment drives up demand for sophisticated surgical devices, resulting in total market growth.

Global Stereotactic Surgery Devices Market Regional Analysis

Here is a more detailed regional analysis of the global stereotactic surgery devices market:

North America:

• The North American region currently dominates the stereotactic surgery equipment market, thanks to its advanced healthcare infrastructure, major research institutes, and large patient population suffering from neurological disorders. The high prevalence of neurological events, such as strokes, contributes greatly to this demand; the Centers for Disease Control and Prevention (CDC) says that roughly 795,000 strokes occur in the United States each year, many of which could benefit from stereotactic therapies. The National Brain Tumor Society believes that approximately 700,000 Americans have a primary brain tumor, with a projected 89,000 new diagnoses in 2024. The growing reliance on stereotactic radiosurgery for brain malignancies drives the expansion of this market sector.
• The North American stereotactic surgery devices market is expected to maintain its dominant position. The increase in the number of neurosurgeons from 3,500 in 2012 to over 5,700 in 2024 represents a developing field that will increasingly rely on stereotactic technology. The increase in the number of neurosurgeons from 3,500 in 2012 to over 5,700 in 2024 represents a developing field that will increasingly rely on stereotactic technology. The US Food and Drug Administration (FDA) has fostered innovation by approving new devices, such as 7D Surgical's MvIGS system in 2021, demonstrating continued progress in this field. As the population ages, with forecasts predicting that by 2030, one in every five Americans will be 65 or older, the demand for effective neurological treatment alternatives is likely to increase, propelling market expansion even further.

Asia Pacific:

• The Asia Pacific region is rapidly emerging as the fastest-growing market for stereotactic surgery devices, owing to a combination of factors such as the rising prevalence of neurological diseases, rising disposable income, increased awareness of advanced treatment options, and significant government initiatives aimed at improving healthcare infrastructure. The World Health Organization (WHO) highlights neurological illnesses as a prominent cause of disability and mortality in this region, with the Global Burden of Disease Study 2019 estimating 150 million disability-adjusted life years (DALYs) in Southeast Asia. This urgent need for efficient treatment solutions is driving up demand for stereotactic surgery as an advanced intervention for illnesses such as brain tumors, which are becoming more common.
• The Asia Pacific stereotactic surgery devices market is poised for significant expansion. This expansion is further aided by government programs such as China's "Healthy China 2030" plan, which intends to increase healthcare expenditures and technology adoption, and India's National Health Policy 2017, which aims to raise public health expenditure.
• Rapid urbanization and rising disposable incomes in countries such as China and India are also driving market growth, as more people have access to innovative medical treatments. As knowledge of these new solutions rises, along with continued improvements in healthcare infrastructure, the Asia Pacific stereotactic surgical devices market is likely to continue its rapid expansion, potentially outpacing other global markets.

Global Stereotactic Surgery Devices Market: Segmentation Analysis

The Global Stereotactic Surgery Devices Market is Segmented on the basis of Product Type, Application, And Geography.

Stereotactic Surgery Devices Market, By Product Type

• Gamma Knife
• Line Accelerator (LINAC) Machines
• Proton Beam
• CyberKnife

Based on Product Type, the market is bifurcated into Gamma Knife, Line Accelerator (LINAC) Machines, Proton Beam, and CyberKnife. Gamma Knife technology is currently dominant due to its proven effectiveness in treating brain tumors and other neurological problems. The Gamma Knife, known for its precision in delivering large doses of radiation while limiting damage to surrounding healthy tissues, has become a preferred choice for neurosurgeons, contributing to its widespread use. CyberKnife is emerging as the fastest-growing segment, thanks to its adaptability and capacity to treat tumors in a variety of sites across the body. Unlike older methods, CyberKnife employs real-time imaging and robotic technology, making non-invasive treatments more appealing to patients and healthcare providers. This expansion is aided by advances in robotic technology and increased knowledge of minimally invasive treatment choices.

Stereotactic Surgery Devices Market, By Application

• Arteriovenous Malformations Treatment
• Brain Tumor Treatment
• Epilepsy
• Parkinson's Disease

Based on Application, the market is segmented into Arteriovenous Malformations Treatment, Brain Tumor Treatment, Epilepsy, and Parkinson's Disease. The Brain Tumor sector is currently a leading due to the high occurrence of primary and metastatic brain tumors, which require precision treatment options such as stereotactic radiosurgery. This segment benefits from modern technology that improve treatment outcomes while minimizing dangers. The Epilepsy segment is expanding at a rapid pace, owing to increased understanding and adoption of stereotactic approaches for treating intractable seizures. As more patients look for alternatives to medication, the need for less invasive techniques such stereotactic surgery to target seizure foci is fast increasing, driving growth in this market.

Stereotactic Surgery Devices Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the World
• On the basis of Geography, the Global Stereotactic Surgery Devices Market is classified into North America, Europe, Asia Pacific, and the Rest of the World. The North American region currently dominates the market for stereotactic surgery devices due to its advanced healthcare infrastructure, strong research base, and large patient population. However, the Asia-Pacific region is witnessing the fastest rise, owing to an increase in the frequency of neurological disorders, rising disposable income, and more awareness of improved treatment alternatives. This region is also benefiting from positive government initiatives and investments in healthcare infrastructure.

Key Players

The "Global Stereotactic Surgery Devices Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are Ion Beam Applications S.A., Mevion Medical Systems, Varian Medical Systems, Monteris Medical, Elekta AB, Micromar, Accuracy Incorporated, Inomed, Alliance Oncology, and Medical AG. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

• Stereotactic Surgery Devices Market Recent Developments
• In February 2024, Elekta enhanced its Asian market position with the acquisition of Premier Business Inter (PBI), a Thai distributor.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL STEREOTACTIC SURGERY DEVICES MARKET

• 1.1 Overview of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL STEREOTACTIC SURGERY DEVICES MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porters Five Force Model
• 4.4 Value Chain Analysis

5 GLOBAL STEREOTACTIC SURGERY DEVICES MARKET, BY PRODUCT TYPE

• 5.1 Overview
• 5.2 Gamma knife
• 5.3 Line accelerator (LINAC) machines
• 5.4 Proton beam
• 5.5 CyberKnife

6 GLOBAL STEREOTACTIC SURGERY DEVICES MARKET, BY APPLICATION

• 6.1 Overview
• 6.2 Arteriovenous malformations treatment
• 6.3 Brain tumor treatment
• 6.4 Epilepsy
• 6.5 Parkinson's disease
• 6.6 Trigeminal Neuralgia

7 GLOBAL STEREOTACTIC SURGERY DEVICES MARKET, BY GEOGRAPHY

• 7.1 Overview
• 7.2 North America
  • 7.2.1 U.S.
  • 7.2.2 Canada
  • 7.2.3 Mexico
• 7.3 Europe
  • 7.3.1 Germany
  • 7.3.2 U.K.
  • 7.3.3 France
  • 7.3.4 Rest of Europe
• 7.4 Asia Pacific
  • 7.4.1 China
  • 7.4.2 Japan
  • 7.4.3 India
  • 7.4.4 Rest of Asia Pacific
• 7.5 Rest of the World
  • 7.5.1 Latin America
  • 7.5.2 Middle East & Africa

8 GLOBAL STEREOTACTIC SURGERY DEVICES MARKET COMPETITIVE LANDSCAPE

• 8.1 Overview
• 8.2 Company Market Ranking
• 8.3 Key Development Strategies

9 COMPANY PROFILES

• 9.1 Ion Beam Applications S.A.
  • 9.1.1 Overview
  • 9.1.2 Financial Performance
  • 9.1.3 Product Outlook
  • 9.1.4 Key Developments
• 9.2 Mevion Medical Systems
  • 9.2.1 Overview
  • 9.2.2 Financial Performance
  • 9.2.3 Product Outlook
  • 9.2.4 Key Developments
• 9.3 Varian Medical Systems
  • 9.3.1 Overview
  • 9.3.2 Financial Performance
  • 9.3.3 Product Outlook
  • 9.3.4 Key Developments
• 9.4 Monteris Medical
  • 9.4.1 Overview
  • 9.4.2 Financial Performance
  • 9.4.3 Product Outlook
  • 9.4.4 Key Developments
• 9.5 Elekta AB
  • 9.5.1 Overview
  • 9.5.2 Financial Performance
  • 9.5.3 Product Outlook
  • 9.5.4 Key Developments
• 9.6 Micromar
  • 9.6.1 Overview
  • 9.6.2 Financial Performance
  • 9.6.3 Product Outlook
  • 9.6.4 Key Developments
• 9.7 Accuracy Incorporated
  • 9.7.1 Overview
  • 9.7.2 Financial Performance
  • 9.7.3 Product Outlook
  • 9.7.4 Key Developments
• 9.8 Inomed
  • 9.8.1 Overview
  • 9.8.2 Financial Performance
  • 9.8.3 Product Outlook
  • 9.8.4 Key Developments
• 9.9 Alliance Oncology
  • 9.9.1 Overview
  • 9.9.2 Financial Performance
  • 9.9.3 Product Outlook
  • 9.9.4 Key Developments
• 9.10 Medical AG
  • 9.10.1 Overview
  • 9.10.2 Financial Performance
  • 9.10.3 Product Outlook
  • 9.10.4 Key Developments

10 Appendix

• 10.1 Related Research